Sanofi (SNY) Inventory (2009 - 2025)

Sanofi (SNY) has 17 years of Inventory data on file, last reported at $11.9 billion in Q4 2025.

• Quarterly Inventory rose 17.98% year-over-year to $11.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.9 billion (up 17.98% YoY) and the FY2025 annual result came in at $11.9 billion, up 17.98% from the prior year.
• Inventory rose to $11.9 billion in Q4 2025 per SNY's latest filing, from $10.9 billion in the prior quarter.
• The five-year high for Inventory was $11.9 billion in Q4 2025, with the low at $9.1 billion in Q4 2022.
• Average Inventory over 5 years is $10.6 billion, with a median of $10.6 billion recorded in 2023.
• Year-over-year, Inventory retreated 10.39% in 2022 and climbed 17.98% in 2025.
• Sanofi's Inventory stood at $10.0 billion in 2021, then fell by 8.31% to $9.1 billion in 2022, then rose by 13.77% to $10.4 billion in 2023, then dropped by 3.1% to $10.1 billion in 2024, then advanced by 17.98% to $11.9 billion in 2025.
• Business Quant data shows SNY's Inventory at $11.9 billion in Q4 2025, $10.9 billion in Q2 2025, and $10.1 billion in Q4 2024.